| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1785 | 2019 |
| SARS-CoV-2 variants B. 1.351 and P. 1 escape from neutralizing antibodies M Hoffmann, P Arora, R Groß, A Seidel, BF Hörnich, AS Hahn, N Krüger, ... Cell 184 (9), 2384-2393. e12, 2021 | 971 | 2021 |
| The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic M Hoffmann, N Krüger, S Schulz, A Cossmann, C Rocha, A Kempf, ... Cell 185 (3), 447-456. e11, 2022 | 876 | 2022 |
| SARS-CoV-2 variant B. 1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination M Hoffmann, H Hofmann-Winkler, N Krüger, A Kempf, I Nehlmeier, ... Cell Reports 36 (3), 109415, 2021 | 265 | 2021 |
| A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry K Pracht, J Meinzinger, P Daum, SR Schulz, D Reimer, M Hauke, E Roth, ... European journal of immunology 47 (8), 1389-1392, 2017 | 128 | 2017 |
| PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing AL Gavin, D Huang, C Huber, A Mårtensson, V Tardif, PD Skog, TR Blane, ... Nature immunology 19 (9), 942-953, 2018 | 100 | 2018 |
| SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization M Hoffmann, L Zhang, N Krüger, L Graichen, H Kleine-Weber, ... Cell reports 35 (3), 109017, 2021 | 97 | 2021 |
| Molecular epidemiology of Staphylococcus aureus in the general population in Northeast Germany: results of the study of health in Pomerania (SHIP-TREND-0) S Holtfreter, D Grumann, V Balau, A Barwich, J Kolata, A Goehler, ... Journal of clinical microbiology 54 (11), 2774-2785, 2016 | 92 | 2016 |
| Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA. 1, BA. 2, and BA. 3 P Arora, L Zhang, C Rocha, A Sidarovich, A Kempf, S Schulz, ... The Lancet. Infectious Diseases 22 (6), 766, 2022 | 90 | 2022 |
| B. 1.617. 2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination P Arora, A Sidarovich, N Krüger, A Kempf, I Nehlmeier, L Graichen, ... Cell reports 37 (2), 109825, 2021 | 71 | 2021 |
| SARS-CoV-2 variants B. 1.351 and B. 1.1. 248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination M Hoffmann, P Arora, R Groß, A Seidel, B Hörnich, A Hahn, N Krüger, ... BioRxiv, 2021.02. 11.430787, 2021 | 60 | 2021 |
| Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability DL Burnett, KJL Jackson, DB Langley, A Aggarwal, AO Stella, ... Immunity 54 (12), 2908-2921. e6, 2021 | 48 | 2021 |
| Delta variant (B. 1.617. 2) sublineages do not show increased neutralization resistance P Arora, A Kempf, I Nehlmeier, L Graichen, A Sidarovich, MS Winkler, ... Cellular & molecular immunology 18 (11), 2557-2559, 2021 | 40 | 2021 |
| A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model AS Peter, E Roth, SR Schulz, K Fraedrich, T Steinmetz, D Damm, ... European Journal of Immunology, 2021 | 36 | 2021 |
| Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry E Qing, P Li, L Cooper, S Schulz, HM Jäck, L Rong, S Perlman, ... Cell reports 39 (5), 110786, 2022 | 34 | 2022 |
| The spike protein of SARS-CoV-2 variant A. 30 is heavily mutated and evades vaccine-induced antibodies with high efficiency P Arora, C Rocha, A Kempf, I Nehlmeier, L Graichen, MS Winkler, M Lier, ... Cellular & molecular immunology 18 (12), 2673-2675, 2021 | 30 | 2021 |
| The microprocessor component, DGCR8, is essential for early B‐cell development in mice A Brandl, P Daum, S Brenner, SR Schulz, DYH Yap, MR Bösl, J Wittmann, ... European journal of immunology 46 (12), 2710-2718, 2016 | 27 | 2016 |
| B Cell Speed and B-FDC Contacts in Germinal Centers Determine Plasma Cell Output via Swiprosin-1/EFhd2 D Reimer, M Meyer-Hermann, A Rakhymzhan, T Steinmetz, P Tripal, ... Cell Reports 32 (6), 108030, 2020 | 21 | 2020 |
| Evidence for an ACE2-independent entry pathway that can protect from neutralization by an antibody used for COVID-19 therapy M Hoffmann, A Sidarovich, P Arora, N Krüger, I Nehlmeier, A Kempf, ... Mbio 13 (3), e00364-22, 2022 | 19 | 2022 |
| miR‐148a controls metabolic programming and survival of mature CD19‐negative plasma cells in mice K Pracht, J Meinzinger, SR Schulz, P Daum, J Côrte‐Real, M Hauke, ... European Journal of Immunology 51 (5), 1089-1109, 2021 | 18 | 2021 |
